UCB is shaking up its leadership team “to better align with its commitment to growth and innovation, and to better address ...

Gilead Sci­ences notched “fine” sales for the first quar­ter but the bio­phar­ma promised more to come. Gilead re­port­ed ...

GSK says it is owed a portion of Pfizer and BioNTech’s Covid-19 vaccine sales in the latest patent suit filed against the ...

Sage Ther­a­peu­tics is dou­bling down on the “block­buster po­ten­tial” of its post­par­tum de­pres­sion drug Zurzu­vae, ...

AstraZeneca put the spotlight on its near-20% revenue growth during first-quarter earnings, driven in part by its success in ...

As part of its sweeping $1.5 billion cost-cutting measure, Bristol Myers Squibb is culling “about 12” programs from its ...

Merck KGaA is allocating over €300 million ($321.8 million) to build a new research building at its headquarters in Darmstadt ...

Regeneron is expanding its genetic medicine efforts and will work with California startup Mammoth Biosciences on gene-editing ...

Roche on Wednesday morning said it has “minor exposure” from the Biosecure Act, adding that it is making strides in China’s ...

UnitedHealth Group’s Optum is shutting down its virtual care business, Endpoints News has learned. Known as Optum Virtual ...

Flindr Therapeutics has secured €20 million ($21 million) in a Series A raise aimed at advancing its lead program through an ...

Moderna has teamed up with OpenAI to bring its GPT technology to drug development. The collaboration, which a Moderna ...